Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KSL Diagnostics is a national reference laboratory providing integrated clinical services focused on diagnostic, prognostic, therapeutic and disease-monitoring information. The company launched a first-of-its-kind COVID-19 Immune Index™ antibody test in April 2022 that measures degree of immunity from COVID-19, receiving FDA Emergency Use Authorization. They also provide comprehensive COVID-19 testing panel including antigen, antibody and RT-PCR tests.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KSL Diagnostics.